C12N 2501/115
Basic fibroblast growth factor
Official title: Basic fibroblast growth factor (bFGF, FGF-2)
C12N2501/115 (Basic fibroblast growth factor) appears on 1,470 US grants and 3,153 published applications in this corpus.
Search patents in C12N- Granted patents
- 1,470
- Published applications
- 3,153
- Assignees
- 1,142
- Inventors
- 4,997
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 4 | 0 |
| 1998 | 3 | 0 |
| 1999 | 5 | 0 |
| 2000 | 10 | 0 |
| 2001 | 9 | 7 |
| 2002 | 11 | 34 |
| 2003 | 18 | 69 |
| 2004 | 14 | 41 |
| 2005 | 14 | 81 |
| 2006 | 17 | 85 |
| 2007 | 19 | 80 |
| 2008 | 20 | 86 |
| 2009 | 38 | 101 |
| 2010 | 27 | 117 |
| 2011 | 33 | 108 |
| 2012 | 61 | 122 |
| 2013 | 49 | 110 |
| 2014 | 69 | 116 |
| 2015 | 79 | 128 |
| 2016 | 100 | 139 |
| 2017 | 80 | 145 |
| 2018 | 87 | 137 |
| 2019 | 84 | 166 |
| 2020 | 89 | 185 |
| 2021 | 82 | 174 |
| 2022 | 77 | 188 |
| 2023 | 81 | 188 |
| 2024 | 107 | 224 |
| 2025 | 103 | 185 |
| 2026 | 74 | 137 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Induced pluripotent stem cell derived glial enriched progenitor cells for the treatment of white matter stroke6 Oct 2026US 12,751,976 B2The Regents of the University of California
- High-purity mesenchymal stem cells6 Oct 2026US 12,753,391 B2Purec Co., Ltd.
- Haematopoietic stem/progenitor cells29 Sep 2026US 12,747,424 B2Murdoch Childrens Research Institute
- Functional cortical organoids, methods of making, and uses thereof15 Sep 2026US 12,736,527 B2The Regents of the University of California
- Methods and compositions for generating oligodendrocyte progenitor cells8 Sep 2026US 12,729,368 B2Trailhead Biosystems Inc.
- Methods and compositions related to platelet releasate and platelet-rich fibrin8 Oct 2026US 2026/0306546 A1Biobridge Global
- Cryopreserved endocrine cells that express chromogranin a1 Oct 2026US 2026/0294981 A1ViaCyte, Inc.
- Method of producing a mesodermal-lineage primitive streak cell1 Oct 2026US 2026/0297533 A1Kyoto University
- Oct3/4 protein variants, and method for producing induced pluripotent stem cells1 Oct 2026US 2026/0297535 A1Riken
- Reprogramming methods and cell culture platforms1 Oct 2026US 2026/0297537 A1Fate Therapeutics, Inc.
Most cited
By later US patents
- Three-dimensional polymer matrices268US 6,471,993 B1Massachusetts Institute of Technology · 2002
- Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals223US 5,753,506 ACNS Stem Cell Technology, Inc. · 1998
- Pluripotential embryonic stem cells and methods of making same205US 5,453,357 AVanderbilt University · 1995
- Human CNS neural stem cells194US 5,968,829 ACytoTherapeutics, Inc. · 1999
- Chondrocyte media formulations and culture procedures192US 6,150,163 AGenzyme Corporation · 2000